Will Clarivate generate free cash flow above $400M in FY2026?

FY2025 FCF was $365M. Management guides ~$400M for FY2026 (10% growth). The path to $400M is plausible: EBITDA margin expansion from 41% to 43% provides ~$20M incremental EBITDA, CapEx declining $15M from disposals, and lower restructuring costs per guidance. The company met full-year guidance for the first time in years in FY2025, and raised guidance multiple times through the year — suggesting conservative initial guidance. However, this is the first time this management team is guiding to $400M, and LS&H sale-related costs (if process advances) could consume cash. Slightly above coin-flip given the clear operational levers.

The $400M FCF target is management's own guidance, and this management team has a pattern of conservative guidance (raised multiple times in 2025). The operational levers are real: 200bps margin expansion, $15M CapEx savings, lower restructuring costs. However, the target is aggressive enough that any miss on revenue, unexpected costs, or working capital timing could cause a shortfall. FCF is also affected by items outside EBITDA — cash taxes, interest payments, and working capital movements. Given the company's history of disappointing on targets, exact coin-flip is appropriate.

The 34% EBITDA-to-FCF conversion rate suggests meaningful cash leakage from interest, taxes, and CapEx. Improving this conversion through CapEx reduction and interest savings (from debt prepayment) is the path to $400M. The $200M bond retirement in 2025-2026 reduces cash interest costs. Disposals reduce CapEx requirements. FY2026 guidance was set at a time when the company was guiding conservatively (based on 2025 pattern). The biggest risk is one-off cash costs related to the LS&H sale process or new restructuring that are not in guidance. Slightly above coin-flip.

Management guided ~$400M FCF, but this is a 10% increase over FY2025. While the operational levers are clear (margin expansion, CapEx reduction), achieving a 10% FCF increase on essentially flat organic revenue requires meaningful cost reduction execution. The LS&H sale process could generate significant advisory and carve-out costs that are not in the FCF guidance. Working capital can be lumpy. Given the company's history of missing targets (first time meeting guidance in FY2025), a moderate skepticism is warranted. Near coin-flip, slightly below.

The trend favors hitting $400M: FCF grew from ~$358M to $365M in FY2025, and the FY2025 guidance was exceeded after multiple raises. Management's pattern of conservative guidance suggests the $400M target has buffer built in. The CapEx reduction from disposals ($15M) and margin expansion (200bps) provide clear incremental FCF. The shift to deleveraging over buybacks in 2026 also means less cash leaving the P&L for shares. Slightly above coin-flip given the conservative guidance pattern.

Coin-flip is the honest assessment. The operational levers support $400M, and management's 2025 track record of exceeding guidance is modestly encouraging. But FCF is the most volatile of Clarivate's guided metrics — it depends on EBITDA delivery, CapEx discipline, working capital timing, and one-off cash costs. Any single component missing by $20M could cause a shortfall. The $400M threshold is exactly at guidance, with no buffer. If the question were $380M, probability would be much higher.

Management guides ~$400M FCF. They met guidance for first time in FY2025. Operational levers are clear but execution on cost reduction required on flat revenue. Near coin-flip.

Conservative guidance pattern (raised multiple times in 2025) suggests $400M has buffer. CapEx reduction and margin expansion provide clear levers. History of missing targets is fading signal given FY2025 achievement. Slightly above coin-flip.

10% FCF growth requires execution on multiple fronts. LS&H sale costs could surprise. Working capital timing is unpredictable. Near coin-flip, slightly below due to execution complexity.